Hybrid Therapy for Spinal Metastases

Robert Rothrock, Zach Pennington, Jeff Ehresman, Mark H. Bilsky, Ori Barzilai, Nicholas J. Szerlip, Daniel M. Sciubba

Research output: Contribution to journalReview articlepeer-review

Abstract

The combination of separation surgery and stereotactic body radiotherapy optimizes the treatment of metastatic spine tumors. The integration of SBRT into treatment paradigms produces superb local control rates and consequently has diminished the role of surgery from principle treatment to one of adjuvant therapy. Under this paradigm, hybrid therapy for the treatment of metastatic spine tumors employs separation surgery to decompress the spinal cord and stabilize the spine while creating a safe target for ablative SBRT. Hybrid therapy is well tolerated, allows an early return to systemic therapy, and provides durable, local tumor control compared with more aggressive traditional approaches.

Original languageEnglish (US)
Pages (from-to)191-200
Number of pages10
JournalNeurosurgery clinics of North America
Volume31
Issue number2
DOIs
StatePublished - Apr 2020

Keywords

  • Hybrid therapy
  • Metastases
  • Radiation
  • Radiosurgery
  • Separation surgery
  • Spinal cord
  • Spine
  • Tumor

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Hybrid Therapy for Spinal Metastases'. Together they form a unique fingerprint.

Cite this